1Shirakawa T;Enomoto T;Shimazu S.The inverse association between tuberculin responses and atopic disorder[J],1997(5296).
2Herz U;Gerhold K;GruberC.BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model[J],1998(5).
3Hopfenspirger MT;Agrawal DK.Airway hyperresponsiveness late allergic response and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice,2002(05).
4Koh YI;Choi IS;Kim WY.Effects of BCG infection on Schultz-Dale reaction allergen-specific IgE levels and Th2 immune response in sensitized rats,2001.
5Wohlleben G;Erb KJ.Atopic disorders: a vaccine around the corner?[J],2001(11).
6Hopfenspirger MT;Parr SK;Hopp RJ.Mycobacterial antigens attenuate late phase response airway hyperresponsiveness and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma[J],2001.
7Major T;Wohlleben G;Reibetanz B.Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced Th2 responses[J],2002(11-12).
8Koh YI;Choi IS;Park SC.BCG infection during pre-sensitization or even post-sensitization inhibits airway sensitivity in an animal model of allergic asthma,2000.
9Scanga CB;Le Gros G.Development of an asthma vaccine:research into BCG[J],2000(6).
10Tokunaga T;Yamamoto H;Shimada S.Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG I Isolation physicochemical characterization and antitumor activity,1984.
